{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:38:18Z","timestamp":1792805898416,"version":"4.5.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10787-025-01641-0","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T04:29:34Z","timestamp":1738211374000},"page":"1311-1330","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Uncovering the intricacies of IGF-1 in Alzheimer\u2019s disease: new insights from regulation to therapeutic targeting"],"prefix":"10.1007","volume":"33","author":[{"given":"Navpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2450-2975","authenticated-orcid":false,"given":"Khadga Raj","family":"Aran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"1641_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1100\/tsw.2006.22","volume":"6","author":"ND \u00c5berg","year":"2006","unstructured":"\u00c5berg ND, Brywe KG, Isgaard J (2006) Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Sci World J 6:53\u201380. https:\/\/doi.org\/10.1100\/tsw.2006.22","journal-title":"Sci World J"},{"issue":"14","key":"1641_CR2","doi-asserted-by":"publisher","first-page":"10203","DOI":"10.1074\/jbc.M611183200","volume":"282","author":"L Adlerz","year":"2007","unstructured":"Adlerz L, Holback S, Multhaup G, Iverfeldt K (2007) IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling pathways. J Biol Chem 282(14):10203\u201310209. https:\/\/doi.org\/10.1074\/jbc.M611183200","journal-title":"J Biol Chem"},{"key":"1641_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neuroscience.2018.01.041","volume":"374","author":"D Aguado-Llera","year":"2018","unstructured":"Aguado-Llera D, Canelles S, Frago LM, Chowen JA, Argente J, Arilla E, Barrios V (2018) The protective effects of IGF-I against \u03b2-amyloid-related downregulation of hippocampal somatostatinergic system involve activation of Akt and protein kinase a. Neuroscience 374:104\u2013118. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.01.041","journal-title":"Neuroscience"},{"issue":"4","key":"1641_CR4","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3233\/JAD-190997","volume":"73","author":"Y Ano","year":"2020","unstructured":"Ano Y, Ohya R, Takaichi Y, Washinuma T, Uchida K, Takashima A, Nakayama H (2020) \u0392-lactolin, a whey-derived lacto-tetrapeptide, prevents Alzheimer\u2019s disease pathologies and cognitive decline. J Alzheimer\u2019s Dis 73(4):1331\u20131342. https:\/\/doi.org\/10.3233\/JAD-190997","journal-title":"J Alzheimer's Dis"},{"issue":"1","key":"1641_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13578-023-00966-z","volume":"13","author":"A Arjunan","year":"2023","unstructured":"Arjunan A, Sah DK, Woo M, Song J (2023) Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome. Cell Biosci 13(1):16. https:\/\/doi.org\/10.1186\/s13578-023-00966-z","journal-title":"Cell Biosci"},{"key":"1641_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jns.2017.03.031","volume":"376","author":"E Bagyinszky","year":"2017","unstructured":"Bagyinszky E, Van Giau V, Shim K, Suk K, An SS, Kim S (2017) Role of inflammatory molecules in the Alzheimer\u2019s disease progression and diagnosis. J Neurol Sci 376:242\u2013254. https:\/\/doi.org\/10.1016\/j.jns.2017.03.031","journal-title":"J Neurol Sci"},{"issue":"11","key":"1641_CR7","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1001\/archneurol.2012.1970","volume":"69","author":"LD Baker","year":"2012","unstructured":"Baker LD, Barsness SM, Borson S, Merriam GR, Friedman SD, Craft S, Vitiello MV (2012) Effects of growth hormone\u2013releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Arch Neurol 69(11):1420\u20131429. https:\/\/doi.org\/10.1001\/archneurol.2012.1970","journal-title":"Arch Neurol"},{"key":"1641_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnagi.2019.00204","volume":"11","author":"P Barbier","year":"2019","unstructured":"Barbier P, Zejneli O, Martinho M, Lasorsa A, Belle V, Smet-Nocca C, Tsvetkov PO, Devred F, Landrieu I (2019) Role of tau as a microtubule-associated protein: structural and functional aspects. Front Aging Neurosci 11:204. https:\/\/doi.org\/10.3389\/fnagi.2019.00204","journal-title":"Front Aging Neurosci"},{"key":"1641_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104896","volume":"142","author":"S Bhalla","year":"2022","unstructured":"Bhalla S, Mehan S, Khan A, Rehman MU (2022) Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions. Neurosci Biobehav Rev 142:104896. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104896","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"1641_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1042\/bst0310292","volume":"31","author":"KU Birkenkamp","year":"2003","unstructured":"Birkenkamp KU, Coffer PJ (2003) Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem Soc Trans 31(1):292\u2013297. https:\/\/doi.org\/10.1042\/bst0310292","journal-title":"Biochem Soc Trans"},{"key":"1641_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fendo.2014.00161","volume":"5","author":"E Bl\u00e1zquez","year":"2014","unstructured":"Bl\u00e1zquez E, Vel\u00e1zquez E, Hurtado-Carneiro V, Ruiz-Albusac JM (2014) Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer\u2019s disease. Front Endocrinol 5:161. https:\/\/doi.org\/10.3389\/fendo.2014.00161","journal-title":"Front Endocrinol"},{"issue":"23","key":"1641_CR12","doi-asserted-by":"publisher","first-page":"17693","DOI":"10.1074\/jbc.M109.096594","volume":"285","author":"M Bolos","year":"2010","unstructured":"Bolos M, Fernandez S, Torres-Aleman I (2010) Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels. J Biol Chem 285(23):17693\u201317700. https:\/\/doi.org\/10.1074\/jbc.M109.096594","journal-title":"J Biol Chem"},{"key":"1641_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neurobiolaging.2019.11.004","volume":"87","author":"L Bonfili","year":"2020","unstructured":"Bonfili L, Cecarini V, Gogoi O, Berardi S, Scarpona S, Angeletti M, Rossi G, Eleuteri AM (2020) Gut microbiota manipulation through probiotics oral administration restores glucose homeostasis in a mouse model of Alzheimer\u2019s disease. Neurobiol Aging 87:35\u201343. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.11.004","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1641_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1152\/ajpendo.90437.2008","volume":"296","author":"S Boura-Halfon","year":"2009","unstructured":"Boura-Halfon S, Zick Y (2009) Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 296(4):581\u2013591. https:\/\/doi.org\/10.1152\/ajpendo.90437.2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"1641_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13195-023-01288-5","volume":"15","author":"Z Cao","year":"2023","unstructured":"Cao Z, Min J, Tan Q, Si K, Yang H, Xu C (2023) Circulating insulin-like growth factor-1 and brain health: Evidence from 369,711 participants in the UK Biobank. Alzheimer\u2019s Res Ther 15(1):140. https:\/\/doi.org\/10.1186\/s13195-023-01288-5","journal-title":"Alzheimer's Res Ther"},{"issue":"9","key":"1641_CR16","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.neurobiolaging.2005.06.015","volume":"27","author":"E Carro","year":"2006","unstructured":"Carro E, Trejo JL, Gerber A, Loetscher H, Torrado J, Metzger F, Torres-Aleman I (2006) Therapeutic actions of insulin-like growth factor I on APP\/PS2 mice with severe brain amyloidosis. Neurobiol Aging 27(9):1250\u20131257. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.06.015","journal-title":"Neurobiol Aging"},{"issue":"12","key":"1641_CR17","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/nm1202-793","volume":"8","author":"E Carro","year":"2002","unstructured":"Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I (2002) Serum insulin-like growth factor I regulates brain amyloid-\u03b2 levels. Nat Med 8(12):1390\u20131397. https:\/\/doi.org\/10.1038\/nm1202-793","journal-title":"Nat Med"},{"issue":"3","key":"1641_CR18","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1534\/genetics.107.072587","volume":"176","author":"V Ch\u00e1vez","year":"2007","unstructured":"Ch\u00e1vez V, Mohri-Shiomi A, Maadani A, Vega LA, Garsin DA (2007) Oxidative stress enzymes are required for DAF-16-mediated immunity due to generation of reactive oxygen species by Caenorhabditis elegans. Genetics 176(3):1567\u20131577. https:\/\/doi.org\/10.1534\/genetics.107.072587","journal-title":"Genetics"},{"issue":"1","key":"1641_CR19","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1038\/s41598-024-53127-8","volume":"14","author":"F Chen","year":"2024","unstructured":"Chen F, Lu K, Bai N, Hao Y, Wang H, Zhao X, Yue F (2024) Oral administration of ellagic acid mitigates perioperative neurocognitive disorders, hippocampal oxidative stress, and neuroinflammation in aged mice by restoring IGF-1 signaling. Sci Rep 14(1):2509. https:\/\/doi.org\/10.1038\/s41598-024-53127-8","journal-title":"Sci Rep"},{"issue":"4","key":"1641_CR20","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s13311-020-00874-x","volume":"17","author":"S Chen","year":"2020","unstructured":"Chen S, Wang T, Yao J, Brinton RD (2020) Allopregnanolone promotes neuronal and oligodendrocyte differentiation in vitro and in vivo: therapeutic implication for Alzheimer\u2019s disease. Neurotherapeutics 17(4):1813\u20131824. https:\/\/doi.org\/10.1007\/s13311-020-00874-x","journal-title":"Neurotherapeutics"},{"issue":"12","key":"1641_CR21","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1210\/en.2005-0063","volume":"146","author":"CM Cheng","year":"2005","unstructured":"Cheng CM, Tseng V, Wang J, Wang D, Matyakhina L, Bondy CA (2005) Tau is hyperphosphorylated in the insulin-like growth factor-I null brain. Endocrinology 146(12):5086\u20135091. https:\/\/doi.org\/10.1210\/en.2005-0063","journal-title":"Endocrinology"},{"issue":"2","key":"1641_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.intimp.2014.01.018","volume":"19","author":"S Chu","year":"2014","unstructured":"Chu S, Gu J, Feng L, Liu J, Zhang M, Jia X, Liu M, Yao D (2014) Ginsenoside Rg5 improves cognitive dysfunction and beta-amyloid deposition in STZ-induced memory impaired rats via attenuating neuroinflammatory responses. Int Immunopharmacol 19(2):317\u2013326. https:\/\/doi.org\/10.1016\/j.intimp.2014.01.018","journal-title":"Int Immunopharmacol"},{"issue":"5793","key":"1641_CR23","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1126\/science.1124646","volume":"313","author":"E Cohen","year":"2006","unstructured":"Cohen E, Bieschke J, Perciavalle RM, Kelly JW, Dillin A (2006) Opposing activities protect against age-onset proteotoxicity. Science 313(5793):1604\u20131610. https:\/\/doi.org\/10.1126\/science.1124646","journal-title":"Science"},{"issue":"4","key":"1641_CR24","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3390\/ijms19040956","volume":"19","author":"N Cort\u00e9s","year":"2018","unstructured":"Cort\u00e9s N, Andrade V, Guzm\u00e1n-Mart\u00ednez L, Estrella M, Maccioni RB (2018) Neuroimmune tau mechanisms: their role in the progression of neuronal degeneration. Int J Mol Sci 19(4):956. https:\/\/doi.org\/10.3390\/ijms19040956","journal-title":"Int J Mol Sci"},{"key":"1641_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neubiorev.2016.01.001","volume":"63","author":"J Costales","year":"2016","unstructured":"Costales J, Kolevzon A (2016) The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders. Neurosci Biobehav Rev 63:207\u2013222. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.01.001","journal-title":"Neurosci Biobehav Rev"},{"issue":"9","key":"1641_CR26","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1038\/sj.emboj.7601062","volume":"25","author":"C Costantini","year":"2006","unstructured":"Costantini C, Scrable H, Puglielli L (2006) An aging pathway controls the TrkA to p75NTR receptor switch and amyloid \u03b2-peptide generation. EMBO J 25(9):1997\u20132006. https:\/\/doi.org\/10.1038\/sj.emboj.7601062","journal-title":"EMBO J"},{"key":"1641_CR27","doi-asserted-by":"crossref","unstructured":"D Skaper S, Facci L, Zusso M, Giusti P (2017) Synaptic plasticity, dementia and Alzheimer disease. CNS Neurol Disord Drug Targets 16(3):220-33","DOI":"10.2174\/1871527316666170113120853"},{"issue":"1","key":"1641_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/ADR-180091","volume":"3","author":"TK Das","year":"2019","unstructured":"Das TK, Chakrabarti SK, Zulkipli IN, Abdul Hamid MR (2019) Curcumin ameliorates the impaired insulin signaling involved in the pathogenesis of Alzheimer\u2019s disease in rats. J Alzheimer\u2019s Dis Rep 3(1):59\u201370. https:\/\/doi.org\/10.3233\/ADR-180091","journal-title":"J Alzheimer's Dis Rep"},{"key":"1641_CR29","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1007\/s00018-003-3305-3","volume":"60","author":"SM De la Monte","year":"2003","unstructured":"De la Monte SM, Chen GJ, Rivera E, Wands JR (2003) Neuronal thread protein regulation and interaction with microtubule-associated proteins in SH-Sy5y neuronal cells. Cell Mol Life Sci 60:2679\u20132691. https:\/\/doi.org\/10.1007\/s00018-003-3305-3","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"1641_CR30","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/00001756-200105080-00047","volume":"12","author":"AG de la Vega","year":"2001","unstructured":"de la Vega AG, Buno W, Pons S, Garcia-Calderat MS, Garcia-Galloway E, Torres-Aleman I (2001) Insulin-like growth factor I potentiates kainate receptors through a phosphatidylinositol 3-kinase dependent pathway. NeuroReport 12(6):1293\u20131296. https:\/\/doi.org\/10.1097\/00001756-200105080-00047","journal-title":"NeuroReport"},{"issue":"5","key":"1641_CR31","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1042\/BST0331101","volume":"33","author":"EA Eckman","year":"2005","unstructured":"Eckman EA, Eckman CB (2005) A\u03b2-degrading enzymes: modulators of Alzheimer\u2019s disease pathogenesis and targets for therapeutic intervention. Biochem Soc Trans 33(5):1101\u20131105. https:\/\/doi.org\/10.1042\/BST0331101","journal-title":"Biochem Soc Trans"},{"issue":"7","key":"1641_CR32","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/0960327112467040","volume":"32","author":"NN Fadl","year":"2013","unstructured":"Fadl NN, Ahmed HH, Booles HF, Sayed AH (2013) Serrapeptase and nattokinase intervention for relieving Alzheimer\u2019s disease pathophysiology in rat model. Hum Exp Toxicol 32(7):721\u2013735. https:\/\/doi.org\/10.1177\/0960327112467040","journal-title":"Hum Exp Toxicol"},{"issue":"7","key":"1641_CR33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/mp.2011.128","volume":"17","author":"AM Fernandez","year":"2012","unstructured":"Fernandez AM, Jimenez S, Mecha M, Davila D, Guaza C, Vitorica J, Torres-Aleman I (2012) Regulation of the phosphatase calcineurin by insulin-like growth factor I unveils a key role of astrocytes in Alzheimer\u2019s pathology. Mol Psychiatry 17(7):705\u2013718. https:\/\/doi.org\/10.1038\/mp.2011.128","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1641_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1677\/jme.0.0330155","volume":"33","author":"M Fernandez","year":"2004","unstructured":"Fernandez M, Sanchez-Franco F, Palacios N, Sanchez I, Fernandez C, Cacicedo L (2004) IGF-I inhibits apoptosis through the activation of the phosphatidylinositol 3-kinase\/Akt pathway in pituitary cells. J Mol Endocrinol 33(1):155\u2013164","journal-title":"J Mol Endocrinol"},{"issue":"7","key":"1641_CR35","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1001\/jamaneurol.2013.1425","volume":"70","author":"SD Friedman","year":"2013","unstructured":"Friedman SD, Baker LD, Borson S, Jensen JE, Barsness SM, Craft S, Merriam GR, Otto RK, Novotny EJ, Vitiello MV (2013) Growth Hormone-Releasing Hormone effects on brain \u03b3-Aminobutyric acid levels in mild cognitive impairment and healthy aging. JAMA Neurol 70(7):883\u2013890. https:\/\/doi.org\/10.1001\/jamaneurol.2013.1425","journal-title":"JAMA Neurol"},{"issue":"7","key":"1641_CR36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1023\/A:1018581407804","volume":"26","author":"LM Garcia-Segura","year":"1997","unstructured":"Garcia-Segura LM, Rodriguez JR, Torres-Aleman I (1997) Localization of the insulin-like growth factor I receptor in the cerebellum and hypothalamus of adult rats: an electron microscopic study. J Neurocytol 26(7):479\u2013490. https:\/\/doi.org\/10.1023\/A:1018581407804","journal-title":"J Neurocytol"},{"key":"1641_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.nutres.2020.12.010","volume":"86","author":"J Go","year":"2021","unstructured":"Go J, Chang DH, Ryu YK, Park HY, Lee IB, Noh JR, Hwang DY, Kim BC, Kim KS, Lee CH (2021) Human gut microbiota Agathobaculum butyriciproducens improves cognitive impairment in LPS-induced and APP\/PS1 mouse models of Alzheimer\u2019s disease. Nutr Res 86:96\u2013108. https:\/\/doi.org\/10.1016\/j.nutres.2020.12.010","journal-title":"Nutr Res"},{"issue":"1","key":"1641_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13311-014-0313-y","volume":"12","author":"GK Gouras","year":"2015","unstructured":"Gouras GK, Olsson TT, Hansson O (2015) \u03b2-Amyloid peptides and amyloid plaques in Alzheimer\u2019s disease. Neurotherapeutics 12(1):3\u201311. https:\/\/doi.org\/10.1007\/s13311-014-0313-y","journal-title":"Neurotherapeutics"},{"issue":"5","key":"1641_CR39","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/mrd.20832","volume":"75","author":"B Han","year":"2008","unstructured":"Han B, Tong J, Zhu MJ, Ma C, Du M (2008) Insulin-like growth factor-1 (IGF-1) and leucine activate pig myogenic satellite cells through mammalian target of rapamycin (mTOR) pathway. Mol Reprod Dev 75(5):810\u2013817. https:\/\/doi.org\/10.1002\/mrd.20832","journal-title":"Mol Reprod Dev"},{"issue":"1","key":"1641_CR40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.nbd.2007.01.004","volume":"26","author":"ML Hemming","year":"2007","unstructured":"Hemming ML, Selkoe DJ, Farris W (2007) Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid \u03b2-protein metabolism in mouse models of Alzheimer disease. Neurobiol Dis 26(1):273\u2013281. https:\/\/doi.org\/10.1016\/j.nbd.2007.01.004","journal-title":"Neurobiol Dis"},{"key":"1641_CR41","doi-asserted-by":"publisher","unstructured":"Herrera ML, Champarini LG, Oliveros AL, Bellini MJ, Here\u00f1\u00fa CB (2024) Potentialities of IGF-1 for regulating oxidative stress in neuroinflammation and neurodegeneration: theoretical review. Explor neuroprot ther 4(6):442\u201358. https:\/\/doi.org\/10.37349\/ent.2024.00093","DOI":"10.37349\/ent.2024.00093"},{"issue":"24","key":"1641_CR42","doi-asserted-by":"publisher","first-page":"9675","DOI":"10.3390\/ijms21249675","volume":"21","author":"R Herrero-Labrador","year":"2020","unstructured":"Herrero-Labrador R, Trueba-Saiz A, Martinez-Rachadell L, Fernandez de Sevilla ME, Zegarra-Valdivia JA, Pignatelli J, Diaz-Pacheco S, Fernandez AM, Torres Aleman I (2020) Circulating insulin-like growth factor I is involved in the effect of high fat diet on peripheral amyloid \u03b2 clearance. Int J Mol Sci 21(24):9675. https:\/\/doi.org\/10.3390\/ijms21249675","journal-title":"Int J Mol Sci"},{"issue":"31","key":"1641_CR43","doi-asserted-by":"publisher","first-page":"19547","DOI":"10.1074\/jbc.272.31.19547","volume":"272","author":"M Hong","year":"1997","unstructured":"Hong M, Lee VM (1997) Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 272(31):19547\u201319553. https:\/\/doi.org\/10.1074\/jbc.272.31.19547","journal-title":"J Biol Chem"},{"issue":"26","key":"1641_CR44","doi-asserted-by":"publisher","first-page":"17941","DOI":"10.1074\/jbc.M601372200","volume":"281","author":"SM Huang","year":"2006","unstructured":"Huang SM, Mouri A, Kokubo H, Nakajima R, Suemoto T, Higuchi M, Staufenbiel M, Noda Y, Yamaguchi H, Nabeshima T, Saido TC (2006) Neprilysin-sensitive synapse-associated amyloid-\u03b2 peptide oligomers impair neuronal plasticity and cognitive function. J Biol Chem 281(26):17941\u201317951. https:\/\/doi.org\/10.1074\/jbc.M601372200","journal-title":"J Biol Chem"},{"issue":"14","key":"1641_CR45","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.3390\/ijms21144977","volume":"21","author":"AC Improta-Caria","year":"2020","unstructured":"Improta-Caria AC, Nonaka CK, Cavalcante BR, De Sousa RA, Aras Junior R, Souza BS (2020) Modulation of microRNAs as a potential molecular mechanism involved in the beneficial actions of physical exercise in Alzheimer disease. Int J Mol Sci 21(14):4977. https:\/\/doi.org\/10.3390\/ijms21144977","journal-title":"Int J Mol Sci"},{"issue":"14","key":"1641_CR46","doi-asserted-by":"publisher","first-page":"10223","DOI":"10.1074\/jbc.M109.038224","volume":"285","author":"KT Jacobsen","year":"2010","unstructured":"Jacobsen KT, Adlerz L, Multhaup G, Iverfeldt K (2010) Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-\u03b2 precursor protein (APP) and APP-like protein 2 is mediated by different metalloproteinases. J Biol Chem 285(14):10223\u201310231. https:\/\/doi.org\/10.1074\/jbc.M109.038224","journal-title":"J Biol Chem"},{"issue":"12","key":"1641_CR47","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1042\/CS20150312","volume":"129","author":"G Jiang","year":"2015","unstructured":"Jiang G, Wang W, Cao Q, Gu J, Mi X, Wang K, Chen G, Wang X (2015) Insulin growth factor-1 (IGF-1) enhances hippocampal excitatory and seizure activity through IGF-1 receptor-mediated mechanisms in the epileptic brain. Clin Sci 129(12):1047\u20131060. https:\/\/doi.org\/10.1042\/CS20150312","journal-title":"Clin Sci"},{"issue":"21","key":"1641_CR48","doi-asserted-by":"publisher","first-page":"18414","DOI":"10.1074\/jbc.M110.209718","volume":"286","author":"S Jimenez","year":"2011","unstructured":"Jimenez S, Torres M, Vizuete M, Sanchez-Varo R, Sanchez-Mejias E, Trujillo-Estrada L, Carmona-Cuenca I, Caballero C, Ruano D, Gutierrez A, Vitorica J (2011) Age-dependent accumulation of soluble amyloid \u03b2 (A\u03b2) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-\u03b1 (sAPP\u03b1) by modulating phosphatidylinositol 3-kinase (PI3K)\/Akt-GSK-3\u03b2 pathway in Alzheimer mouse model. J Biol Chem 286(21):18414\u201318425. https:\/\/doi.org\/10.1074\/jbc.M110.209718","journal-title":"J Biol Chem"},{"issue":"1","key":"1641_CR49","doi-asserted-by":"publisher","first-page":"8187","DOI":"10.1038\/srep08187","volume":"5","author":"N Jin","year":"2015","unstructured":"Jin N, Yin X, Yu D, Cao M, Gong CX, Iqbal K, Ding F, Gu X, Liu F (2015) Truncation and activation of GSK-3\u03b2 by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer\u2019s disease. Sci Rep 5(1):8187. https:\/\/doi.org\/10.1038\/srep08187","journal-title":"Sci Rep"},{"issue":"3","key":"1641_CR50","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.bbrc.2007.04.201","volume":"358","author":"YH Joung","year":"2007","unstructured":"Joung YH, Lee MY, Lim EJ, Kim MS, Hwang TS, Kim SY, Ye SK, Lee JD, Park T, Woo YS, Chung IM (2007) Hypoxia activates the IGF-1 expression through STAT5b in human HepG2 cells. Biochem Biophys Res Commun 358(3):733\u2013738. https:\/\/doi.org\/10.1016\/j.bbrc.2007.04.201","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"1641_CR51","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3390\/v13081488b","volume":"13","author":"A J\u00f3zefiak","year":"2021","unstructured":"J\u00f3zefiak A, Larska M, Pomorska-M\u00f3l M, Ruszkowski JJ (2021) The IGF-1 signaling pathway in viral infections. Viruses 13(8):1488. https:\/\/doi.org\/10.3390\/v13081488b","journal-title":"Viruses"},{"issue":"6","key":"1641_CR52","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.3892\/ijo.2012.1666","volume":"41","author":"A Kasprzak","year":"2012","unstructured":"Kasprzak A, Adamek A (2012) The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis. Int J Oncol 41(6):1919\u20131931. https:\/\/doi.org\/10.3892\/ijo.2012.1666","journal-title":"Int J Oncol"},{"issue":"4","key":"1641_CR53","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1210\/en.2017-03175","volume":"159","author":"MJ Lecomte","year":"2018","unstructured":"Lecomte MJ, Bertolus C, Ramanantsoa N, Saurini F, Callebert J, Senamaud-Beaufort C, Ringot M, Bourgeois T, Matrot B, Collet C, Nardelli J (2018) Acetylcholine modulates the hormones of the growth hormone\/insulinlike growth factor-1 axis during development in mice. Endocrinology 159(4):1844\u20131859. https:\/\/doi.org\/10.1210\/en.2017-03175","journal-title":"Endocrinology"},{"key":"1641_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101245","volume":"52","author":"D LeRoith","year":"2021","unstructured":"LeRoith D, Holly JMP, Forbes BE (2021) Insulin-like growth factors: ligands, binding proteins, and receptors. Mol Metab 52:101245. https:\/\/doi.org\/10.1016\/j.molmet.2021.101245","journal-title":"Mol Metab"},{"issue":"S1","key":"1641_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/dom.12337","volume":"16","author":"J Liu","year":"2014","unstructured":"Liu J, Speder P, Brand AH (2014) Control of brain development and homeostasis by local and systemic insulin signalling. Diabetes Obes Metab 16(S1):16\u201320. https:\/\/doi.org\/10.1111\/dom.12337","journal-title":"Diabetes Obes Metab"},{"key":"1641_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2019.112689","volume":"213","author":"P Liu","year":"2020","unstructured":"Liu P, Cui L, Liu B, Liu W, Hayashi T, Mizuno K, Hattori S, Ushiki-Kaku Y, Onodera S, Ikejima T (2020) Silibinin ameliorates STZ-induced impairment of memory and learning by up-regulating insulin signaling pathway and attenuating apoptosis. Physiol Behav 213:112689. https:\/\/doi.org\/10.1016\/j.physbeh.2019.112689","journal-title":"Physiol Behav"},{"key":"1641_CR57","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2013.02.065","volume":"543","author":"P Liu","year":"2013","unstructured":"Liu P, Zou L, Jiao Q, Chi T, Ji X, Qi Y, Xu Q, Wang L (2013) Xanthoceraside attenuates learning and memory deficits via improving insulin signaling in STZ-induced AD rats. Neurosci Lett 543:115\u2013120. https:\/\/doi.org\/10.1016\/j.neulet.2013.02.065","journal-title":"Neurosci Lett"},{"issue":"48","key":"1641_CR58","doi-asserted-by":"publisher","first-page":"50078","DOI":"10.1074\/jbc.M406109200","volume":"279","author":"SJ Liu","year":"2004","unstructured":"Liu SJ, Zhang JY, Li HL, Fang ZY, Wang Q, Deng HM, Gong CX, Grundke-Iqbal I, Iqbal K, Wang JZ (2004) Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain. J Biol Chem 279(48):50078\u201350088. https:\/\/doi.org\/10.1074\/jbc.M406109200","journal-title":"J Biol Chem"},{"key":"1641_CR59","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuropharm.2014.11.018","volume":"96","author":"S Lombardo","year":"2015","unstructured":"Lombardo S, Maskos U (2015) Role of the nicotinic acetylcholine receptor in Alzheimer\u2019s disease pathology and treatment. Neuropharmacology 96:255\u2013262. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.11.018","journal-title":"Neuropharmacology"},{"issue":"3","key":"1641_CR60","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2174\/187153012802002857","volume":"12","author":"J Manuel Gomez Saez","year":"2012","unstructured":"Manuel Gomez Saez J (2012) Possible usefulness of growth hormone\/insulin-like growth factor-I axis in Alzheimer\u2019s disease treatment. Endocr Metab Immune Disord Drug Targets 12(3):274\u2013286. https:\/\/doi.org\/10.2174\/187153012802002857","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1641_CR61","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.redox.2017.05.012","volume":"13","author":"E Mart\u00edn-Monta\u00f1ez","year":"2017","unstructured":"Mart\u00edn-Monta\u00f1ez E, Millon C, Boraldi F, Garcia-Guirado F, Pedraza C, Lara E, Santin LJ, Pavia J, Garcia-Fernandez M (2017) IGF-II promotes neuroprotection and neuroplasticity recovery in a long-lasting model of oxidative damage induced by glucocorticoids. Redox Biol 13:69\u201381. https:\/\/doi.org\/10.1016\/j.redox.2017.05.012","journal-title":"Redox Biol"},{"issue":"2","key":"1641_CR62","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1471-4159.2010.06929.x","volume":"115","author":"G Marwarha","year":"2010","unstructured":"Marwarha G, Dasari B, Prabhakara JP, Schommer J, Ghribi O (2010) \u03b2-Amyloid regulates leptin expression and tau phosphorylation through the mTORC1 signaling pathway. J Neurochem 115(2):373\u2013384. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06929.x","journal-title":"J Neurochem"},{"key":"1641_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-6-41","volume":"6","author":"G Marwarha","year":"2011","unstructured":"Marwarha G, Prasanthi JR, Schommer J, Dasari B, Ghribi O (2011) Molecular interplay between leptin, insulin-like growth factor-1, and \u03b2-amyloid in organotypic slices from rabbit hippocampus. Mol Neurodegener 6:1\u20138. https:\/\/doi.org\/10.1186\/1750-1326-6-41","journal-title":"Mol Neurodegener"},{"issue":"4","key":"1641_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094287","volume":"9","author":"TJ Mellott","year":"2014","unstructured":"Mellott TJ, Pender SM, Burke RM, Langley EA, Blusztajn JK (2014) IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer\u2019s disease model mice. PLoS ONE 9(4):e94287. https:\/\/doi.org\/10.1371\/journal.pone.0094287","journal-title":"PLoS ONE"},{"key":"1641_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.672392","volume":"12","author":"AJ Montivero","year":"2021","unstructured":"Montivero AJ, Ghersi MS, Silvero CMJ, Artur de la Villarmois E, Catalan-Figueroa J, Herrera M, Becerra MC, Here\u00f1\u00fa CB, P\u00e9rez MF (2021) Early IGF-1 gene therapy prevented oxidative stress and cognitive deficits induced by traumatic brain injury. Front Pharmacol 12:672392. https:\/\/doi.org\/10.3389\/fphar.2021.672392","journal-title":"Front Pharmacol"},{"issue":"8","key":"1641_CR66","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1038\/s41380-023-02136-6","volume":"28","author":"A Nu\u00f1ez","year":"2023","unstructured":"Nu\u00f1ez A, Zegarra-Valdivia J, Fernandez de Sevilla D, Pignatelli J, Torres Aleman I (2023) The neurobiology of insulin-like growth factor I: From neuroprotection to modulation of brain states. Mol Psychiatry 28(8):3220\u20133230. https:\/\/doi.org\/10.1038\/s41380-023-02136-6","journal-title":"Mol Psychiatry"},{"key":"1641_CR67","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neuroscience.2017.04.008","volume":"353","author":"OM Ogundele","year":"2017","unstructured":"Ogundele OM, Ebenezer PJ, Lee CC, Francis J (2017) Stress-altered synaptic plasticity and DAMP signaling in the hippocampus-PFC axis; elucidating the significance of IGF-1\/IGF-1R\/CaMKII\u03b1 expression in neural changes associated with a prolonged exposure therapy. Neuroscience 353:147\u2013165. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.04.008","journal-title":"Neuroscience"},{"key":"1641_CR68","doi-asserted-by":"publisher","first-page":"1459025","DOI":"10.3389\/fnagi.2024.1459025","volume":"16","author":"J Pan","year":"2024","unstructured":"Pan J, Yao Q, Wang Y, Chang S, Li C, Wu Y, Shen J, Yang R (2024) The role of PI3K signaling pathway in Alzheimer\u2019s disease. Front Aging Neurosci 16:1459025. https:\/\/doi.org\/10.3389\/fnagi.2024.1459025","journal-title":"Front Aging Neurosci"},{"key":"1641_CR69","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-94-007-2869-1_1","volume":"942","author":"S Papa","year":"2012","unstructured":"Papa S, Martino PL, Capitanio G, Gaballo A, De Rasmo D, Signorile A, Petruzzella V (2012) The oxidative phosphorylation system in mammalian mitochondria. Adv Mitochondrial Med 942:3\u20137. https:\/\/doi.org\/10.1007\/978-94-007-2869-1_1","journal-title":"Adv Mitochondrial Med"},{"issue":"4","key":"1641_CR70","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1111\/ejn.13278","volume":"44","author":"J Pardo","year":"2016","unstructured":"Pardo J, Uriarte M, C\u00f3nsole GM, Reggiani PC, Outeiro TF, Morel GR, Goya RG (2016) Insulin-like growth factor-I gene therapy increases hippocampal neurogenesis, astrocyte branching and improves spatial memory in female aging rats. Eur J Neurosci 44(4):2120\u20132128. https:\/\/doi.org\/10.1111\/ejn.13278","journal-title":"Eur J Neurosci"},{"key":"1641_CR71","doi-asserted-by":"publisher","unstructured":"Pascual\u2010Lucas M, Viana da Silva S, Di Scala M, Garcia\u2010Barroso C, Gonz\u00e1lez\u2010Aseguinolaza G, Mulle C, Alberini CM, Cuadrado\u2010Tejedor M, Garcia\u2010Osta A (2014) Insulin\u2010like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice. EMBO Mol Med 6(10):1246\u201362. https:\/\/doi.org\/10.15252\/emmm.201404228","DOI":"10.15252\/emmm.201404228"},{"key":"1641_CR72","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.bbadis.2014.05.025","volume":"9","author":"I Pedr\u00f3s","year":"1842","unstructured":"Pedr\u00f3s I, Petrov D, Allgaier M, Sureda F, Barroso E, Beas-Zarate C, Auladell C, Pall\u00e0s M, V\u00e1zquez-Carrera M, Casades\u00fas G (1842) Folch J (2014) Early alterations in energy metabolism in the hippocampus of APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease. Biochim Biophys Acta 9:1556\u20131566. https:\/\/doi.org\/10.1016\/j.bbadis.2014.05.025","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"1641_CR73","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/glia.24163","volume":"70","author":"D Pinto-Benito","year":"2022","unstructured":"Pinto-Benito D, Paradela-Leal C, Ganchala D, de Castro MP, Ar\u00e9valo M\u00c1 (2022) IGF-1 regulates astrocytic phagocytosis and inflammation through the p110\u00bf isoform of PI3K in a sex-specific manner. Glia 70(6):1153\u20131169. https:\/\/doi.org\/10.1002\/glia.24163","journal-title":"Glia"},{"key":"1641_CR74","doi-asserted-by":"publisher","first-page":"1263771","DOI":"10.3389\/fnins.2023.1263771","volume":"17","author":"A Pless","year":"2023","unstructured":"Pless A, Ware D, Saggu S, Rehman H, Morgan J, Wang Q (2023) Understanding neuropsychiatric symptoms in Alzheimer\u2019s disease: challenges and advances in diagnosis and treatment. Front Neurosci 17:1263771. https:\/\/doi.org\/10.3389\/fnins.2023.1263771","journal-title":"Front Neurosci"},{"key":"1641_CR75","doi-asserted-by":"publisher","unstructured":"Porel P, Bala K, Aran KR (2024) Exploring the role of HIF-1\u03b1 on pathogenesis in Alzheimer\u2019s disease and potential therapeutic approaches. Inflammopharmacology Oct 27:1\u201310. https:\/\/doi.org\/10.1007\/s10787-024-01585-x","DOI":"10.1007\/s10787-024-01585-x"},{"issue":"15","key":"1641_CR76","doi-asserted-by":"publisher","first-page":"10761","DOI":"10.1074\/jbc.275.15.10761","volume":"275","author":"S Pugazhenthi","year":"2000","unstructured":"Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE, Reusch JE (2000) Akt\/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 275(15):10761\u201310766. https:\/\/doi.org\/10.1074\/jbc.275.15.10761","journal-title":"J Biol Chem"},{"key":"1641_CR77","doi-asserted-by":"publisher","unstructured":"R. Vose L, K. Stanton P (2017) Synaptic plasticity, metaplasticity and depression. Curr Neuropharmacol 15(1):71-86. https:\/\/doi.org\/10.2174\/1570159X14666160202121111","DOI":"10.2174\/1570159X14666160202121111"},{"issue":"3","key":"1641_CR78","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3233\/jad-2005-8304","volume":"8","author":"EJ Rivera","year":"2005","unstructured":"Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM (2005) Insulin and insulin-like growth factor expres sion and function deteriorate with progression of Alzheimer\u2019s disease: link to brain reductions in acetylcholine. J Alzheimers Dis 8(3):247\u2013268. https:\/\/doi.org\/10.3233\/jad-2005-8304","journal-title":"J Alzheimers Dis"},{"key":"1641_CR79","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.bbadis.2016.03.010","volume":"7","author":"MC S\u00e1daba","year":"1862","unstructured":"S\u00e1daba MC, Mart\u00edn-Estal I, Puche JE (1862) Castilla-Cort\u00e1zar I (2016) Insulin-like growth factor 1 (IGF-1) therapy: Mitochondrial dysfunction and diseases. Biochim Biophys Acta 7:1267\u20131278. https:\/\/doi.org\/10.1016\/j.bbadis.2016.03.010","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1641_CR80","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1212\/WNL.0b013e3181e62076","volume":"75","author":"N Saleh","year":"2010","unstructured":"Saleh N, Moutereau S, Azulay JP, Verny C, Simonin C, Tranchant C, El Hawajri N, Bachoud-L\u00e9vi AC, Maison P (2010) High insulinlike growth factor I is associated with cognitive decline in Huntington disease. Neurology 75(1):57\u201363. https:\/\/doi.org\/10.1212\/WNL.0b013e3181e62076","journal-title":"Neurology"},{"key":"1641_CR81","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s12035-019-01827-y","volume":"57","author":"MC Selles","year":"2020","unstructured":"Selles MC, Fortuna JT, Zappa-Villar MF, de Faria YP, Souza AS, Suemoto CK, Leite RE, Rodriguez RD, Grinberg LT, Reggiani PC, Ferreira ST (2020) Adenovirus-mediated transduction of insulin-like growth factor 1 protects hippocampal neurons from the toxicity of A\u03b2 oligomers and prevents memory loss in an Alzheimer mouse model. Mol Neurobiol 57:1473\u20131483. https:\/\/doi.org\/10.1007\/s12035-019-01827-y","journal-title":"Mol Neurobiol"},{"issue":"21","key":"1641_CR82","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1212\/01.wnl.0000335163.88054.e7","volume":"71","author":"JJ Sevigny","year":"2008","unstructured":"Sevigny JJ, Ryan JM, Van Dyck CH, Peng Y, Lines CR, Nessly ML (2008) Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial. Neurology 71(21):1702\u20131708. https:\/\/doi.org\/10.1212\/01.wnl.0000335163.88054.e7","journal-title":"Neurology"},{"issue":"5","key":"1641_CR83","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/cercor\/bhh158","volume":"15","author":"L Shi","year":"2005","unstructured":"Shi L, Linville MC, Tucker EW, Sonntag WE, Brunso-Bechtold JK (2005) Differential effects of aging and insulin-like growth factor-1 on synapses in CA1 of rat hippocampus. Cereb Cortex 15(5):571\u2013577. https:\/\/doi.org\/10.1093\/cercor\/bhh158","journal-title":"Cereb Cortex"},{"key":"1641_CR84","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00204-014-1448-7","volume":"89","author":"WA Siddiqui","year":"2015","unstructured":"Siddiqui WA, Ahad A, Ahsan H (2015) The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update. Arch Toxicol 89:289\u2013317. https:\/\/doi.org\/10.1007\/s00204-014-1448-7","journal-title":"Arch Toxicol"},{"issue":"4","key":"1641_CR85","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0361-9230(99)00259-2","volume":"51","author":"WE Sonntag","year":"2000","unstructured":"Sonntag WE, Bennett SA, Khan AS, Thornton PL, Xu X, Ingram RL, Brunso-Bechtold JK (2000) Age and insulin-like growth factor-1 modulate N-methyl-D-aspartate receptor subtype expression in rats. Brain Res Bull 51(4):331\u2013338. https:\/\/doi.org\/10.1016\/S0361-9230(99)00259-2","journal-title":"Brain Res Bull"},{"issue":"2","key":"1641_CR86","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.arr.2005.02.001","volume":"4","author":"WE Sonntag","year":"2005","unstructured":"Sonntag WE, Ramsey M, Carter CS (2005) Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res Rev 4(2):195\u2013212. https:\/\/doi.org\/10.1016\/j.arr.2005.02.001","journal-title":"Ageing Res Rev"},{"key":"1641_CR87","doi-asserted-by":"publisher","unstructured":"Steen E, Terry BM, J. Rivera E, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de La Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2013is this type 3 diabetes?. J Alzheimer's Dis 7(1):63-80. https:\/\/doi.org\/10.3233\/JAD-2005-7107","DOI":"10.3233\/JAD-2005-7107"},{"issue":"12","key":"1641_CR88","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1161\/ATVBAHA.107.156257","volume":"27","author":"S Sukhanov","year":"2007","unstructured":"Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P (2007) IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. ATVB 27(12):2684\u20132690. https:\/\/doi.org\/10.1161\/ATVBAHA.107.156257","journal-title":"ATVB"},{"key":"1641_CR89","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.brainresbull.2020.08.026","volume":"164","author":"Z Sun","year":"2020","unstructured":"Sun Z, Wu K, Gu L, Huang L, Zhuge Q, Yang S, Wang Z (2020) IGF-1R stimulation alters microglial polarization via TLR4\/NF-\u03baB pathway after cerebral hemorrhage in mice. Brain Res Bull 164:221\u2013234. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.08.026","journal-title":"Brain Res Bull"},{"issue":"6","key":"1641_CR90","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1471-4159.2011.07623.x","volume":"120","author":"J Tan","year":"2012","unstructured":"Tan J, Evin G (2012) \u03b2-Site APP-cleaving enzyme 1 trafficking and Alzheimer\u2019s disease pathogenesis. J Neurochem 120(6):869\u2013880. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07623.x","journal-title":"J Neurochem"},{"issue":"11","key":"1641_CR91","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.3390\/ijms23115938","volume":"23","author":"DM Teleanu","year":"2022","unstructured":"Teleanu DM, Niculescu AG, Lungu II, Radu CI, Vlad\u00e2cenco O, Roza E, Cost\u0103chescu B, Grumezescu AM, Teleanu RI (2022) An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int J Mol Sci 23(11):5938. https:\/\/doi.org\/10.3390\/ijms23115938","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1641_CR92","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/1389201033489865","volume":"4","author":"J Torrado","year":"2003","unstructured":"Torrado J, Carrascosa C (2003) Pharmacological characteristics of parenteral IGF-I administration. Curr Pharm Biotechnol 4(2):123\u2013140. https:\/\/doi.org\/10.2174\/1389201033489865","journal-title":"Curr Pharm Biotechnol"},{"issue":"12","key":"1641_CR93","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1517\/14728222.11.12.1535","volume":"11","author":"I Torres-Aleman","year":"2007","unstructured":"Torres-Aleman I (2007) Targeting insulin-like growth factor-1 to treat Alzheimer\u2019s disease. Expert Opin Ther Targets 11(12):1535\u20131542. https:\/\/doi.org\/10.1517\/14728222.11.12.1535","journal-title":"Expert Opin Ther Targets"},{"issue":"12","key":"1641_CR94","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/sj.mp.4002076","volume":"12","author":"JL Trejo","year":"2007","unstructured":"Trejo JL, Piriz J, Llorens-Martin MV, Fernandez AM, Bolos M, LeRoith D, Nunez A, Torres-Aleman I (2007) Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects. Mol Psychiatry 12(12):1118\u20131128. https:\/\/doi.org\/10.1038\/sj.mp.4002076","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1641_CR95","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jnc.12715","volume":"130","author":"R Vassar","year":"2014","unstructured":"Vassar R, Kuhn PH, Haass C, Kennedy ME, Rajendran L, Wong PC, Lichtenthaler SF (2014) Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects. J Neurochem 130(1):4\u201328. https:\/\/doi.org\/10.1111\/jnc.12715","journal-title":"J Neurochem"},{"issue":"2","key":"1641_CR96","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.neurobiolaging.2005.01.010","volume":"27","author":"MV Vitiello","year":"2006","unstructured":"Vitiello MV, Moe KE, Merriam GR, Mazzoni G, Buchner DH, Schwartz RS (2006) Growth hormone releasing hormone improves the cognition of healthy older adults. Neurobiol Aging 27(2):318\u2013323. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.01.010","journal-title":"Neurobiol Aging"},{"key":"1641_CR97","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neuropharm.2013.08.022","volume":"76","author":"X Wang","year":"2014","unstructured":"Wang X, Wang LP, Tang H, Shan WY, Wang X, Liu D, Wu YY, Tian Q, Wang JZ, Zhu LQ (2014) Acetyl-L-carnitine rescues scopolamine-induced memory deficits by restoring insulin-like growth factor II via decreasing p53 oxidation. Neuropharmacology 76:80\u201387. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.08.022","journal-title":"Neuropharmacology"},{"key":"1641_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-015-0174-2","volume":"8","author":"K Watanabe","year":"2015","unstructured":"Watanabe K, Uemura K, Asada M, Maesako M, Akiyama H, Shimohama S, Takahashi R, Kinoshita A (2015) The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer\u2019s disease. Mol Brain 8:1\u20134. https:\/\/doi.org\/10.1186\/s13041-015-0174-2","journal-title":"Mol Brain"},{"issue":"18","key":"1641_CR99","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1212\/WNL.0000000000000382","volume":"82","author":"AJ Westwood","year":"2014","unstructured":"Westwood AJ, Beiser A, DeCarli C, Harris TB, Chen TC, He XM, Roubenoff R, Pikula A, Au R, Braverman LE, Wolf PA (2014) Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy. Neurology 82(18):1613\u20131619. https:\/\/doi.org\/10.1212\/WNL.0000000000000382","journal-title":"Neurology"},{"issue":"1","key":"1641_CR100","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-220356","volume":"88","author":"K Wittfeld","year":"2022","unstructured":"Wittfeld K, Raman MR, Conner SC, Aslam A, Teumer A, Nauck M, Hosten N, Habes M, DeCarli C, Vasan RS, Beiser AS (2022) Insulin-like growth factor, inflammation, and MRI markers of Alzheimer\u2019s disease in predominantly middle-aged adults. J Alzheimer\u2019s Dis 88(1):311\u2013322. https:\/\/doi.org\/10.3233\/JAD-220356","journal-title":"J Alzheimer's Dis"},{"issue":"7","key":"1641_CR101","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1017\/S1041610219000383","volume":"31","author":"L Xia","year":"2019","unstructured":"Xia L, Zhu X, Zhao Y, Yang G, Zuo X, Xie P, Chen C, Han Q (2019) Genome-wide RNA sequencing analysis reveals that IGF-2 attenuates memory decline, oxidative stress and amyloid plaques in an Alzheimer\u2019s disease mouse model (AD) by activating the PI3K\/AKT\/CREB signaling pathway. Int Psychogeriatr 31(7):947\u2013959. https:\/\/doi.org\/10.1017\/S1041610219000383","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"1641_CR102","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.expneurol.2007.01.029","volume":"205","author":"C Xing","year":"2007","unstructured":"Xing C, Yin Y, Chang R, Gong X, He X, Xie Z (2007) Effects of insulin-like growth factor 1 on synaptic excitability in cultured rat hippocampal neurons. Exp Neurol 205(1):222\u2013229. https:\/\/doi.org\/10.1016\/j.expneurol.2007.01.029","journal-title":"Exp Neurol"},{"key":"1641_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2020.113236","volume":"229","author":"C Yang","year":"2021","unstructured":"Yang C, Sui G, Li D, Wang L, Zhang S, Lei P, Chen Z, Wang F (2021) Exogenous IGF-1 alleviates depression-like behavior and hippocampal mitochondrial dysfunction in high-fat diet mice. Physiol Behav 229:113236. https:\/\/doi.org\/10.1016\/j.physbeh.2020.113236","journal-title":"Physiol Behav"},{"issue":"10","key":"1641_CR104","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/hipo.23379","volume":"31","author":"MF Zappa Villar","year":"2021","unstructured":"Zappa Villar MF, L\u00f3pez Hanotte J, Crespo R, Pardo J, Reggiani PC (2021) Insulin-like growth factor 1 gene transfer for sporadic Alzheimer\u2019s disease: New evidence for trophic factor mediated hippocampal neuronal and synaptic recovery-based behavior improvement. Hippocampus 31(10):1137\u20131153. https:\/\/doi.org\/10.1002\/hipo.23379","journal-title":"Hippocampus"},{"key":"1641_CR105","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11064-010-0260-x","volume":"36","author":"H Zhang","year":"2011","unstructured":"Zhang H, Gao Y, Dai Z, Meng T, Tu S, Yan Y (2011) IGF-1 reduces BACE-1 expression in PC12 cells via activation of PI3-K\/Akt and MAPK\/ERK1\/2 signaling pathways. Neurochem Res 36:49\u201357. https:\/\/doi.org\/10.1007\/s11064-010-0260-x","journal-title":"Neurochem Res"},{"key":"1641_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135322","volume":"738","author":"W Zhang","year":"2020","unstructured":"Zhang W, Bai S, Yang J, Zhang Y, Liu Y, Nie J, Meng D, Shi R, Yao Z, Wang M, Wang H (2020) FoxO1 overexpression reduces A\u03b2 production and tau phosphorylation in vitro. Neurosci Lett 738:135322. https:\/\/doi.org\/10.1016\/j.neulet.2020.135322","journal-title":"Neurosci Lett"},{"issue":"49","key":"1641_CR107","doi-asserted-by":"publisher","first-page":"11120","DOI":"10.1523\/JNEUROSCI.2860-04.2004","volume":"24","author":"L Zhao","year":"2004","unstructured":"Zhao L, Teter B, Morihara T, Lim GP, Ambegaokar SS, Ubeda OJ, Frautschy SA, Cole GM (2004) Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer\u2019s disease intervention. J Neurosci 24(49):11120\u201311126. https:\/\/doi.org\/10.1523\/JNEUROSCI.2860-04.2004","journal-title":"J Neurosci"},{"issue":"1","key":"1641_CR108","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1096\/fj.06-7703com","volume":"22","author":"WQ Zhao","year":"2008","unstructured":"Zhao WQ, De Felice FG, Fernandez S, Chen H, Lambert MP, Quon MJ, Krafft GA, Klein WL (2008) Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J 22(1):246\u2013260. https:\/\/doi.org\/10.1096\/fj.06-7703com","journal-title":"FASEB J"},{"issue":"6","key":"1641_CR109","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.neurobiolaging.2006.05.001","volume":"28","author":"Z Zhao","year":"2007","unstructured":"Zhao Z, Xiang Z, Haroutunian V, Buxbaum JD, Stetka B, Pasinetti GM (2007) Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer\u2019s disease. Neurobiol Aging 28(6):824\u2013830. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.05.001","journal-title":"Neurobiol Aging"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01641-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01641-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01641-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T09:09:55Z","timestamp":1742288995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01641-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":109,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1641"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01641-0","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"29 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors assert that they do not have any known financial interests or personal relationships that could be perceived as influencing the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}